Anxiety and Depression

February 15, 2018

Molecular therapy for anxiety and depression: Bupropion, an antidepressant medication, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 15/February/2018, 11.05 pm,

Molecular therapy for anxiety and depression: Bupropion, an antidepressant medication, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 15/February/2018, 11.05 pm, https://genomediscovery.org/wp-content/uploads/2018/02/Bupropion-inhibits-PHF8.JMJD1_.2-expressionlevels-and-attenuates-anxiety-and-depression.1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/Bupropion-inhibits-PHF8.JMJD1_.2-expressionlevels-and-attenuates-anxiety-and-depression.1.jpg February 15, 2018 February 15, 2018

Introduction: What they say: A study from Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA; Department of Stem Cell and…

January 31, 2018

Molecular therapy for anxiety and depression: Chlorpromazine [Trade name: Thorazine and Largactil], an antipsychotic medication, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 31/January/2018, 11.23 pm

Molecular therapy for anxiety and depression: Chlorpromazine [Trade name: Thorazine and Largactil], an antipsychotic medication, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 31/January/2018, 11.23 pm https://genomediscovery.org/wp-content/uploads/2018/01/Chlorpromazine-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Chlorpromazine-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg January 31, 2018 January 31, 2018

January 30, 2018

Molecular therapy for anxiety and depression: Sertraline (Brand name: Zoloft, Lustral) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 30/January/2018, 11.33 pm

Molecular therapy for anxiety and depression: Sertraline (Brand name: Zoloft, Lustral) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 30/January/2018, 11.33 pm https://genomediscovery.org/wp-content/uploads/2018/01/Sertraline-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Sertraline-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg January 30, 2018 January 30, 2018

January 29, 2018

Molecular therapy for anxiety and depression: Isorhapontigeninn, isolated from Norway spruce, and Sitka spruce among others , decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 29/January/2018, 10.52 pm

Molecular therapy for anxiety and depression: Isorhapontigeninn, isolated from Norway spruce, and Sitka spruce among others , decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 29/January/2018, 10.52 pm https://genomediscovery.org/wp-content/uploads/2018/01/ISORHA2.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/ISORHA2.jpg January 29, 2018 January 29, 2018

January 28, 2018

Molecular therapy for anxiety and depression: Tanshinone IIA, isolated from Salvia miltiorrhiza, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 28/January/2018, 10.51 pm

Molecular therapy for anxiety and depression: Tanshinone IIA, isolated from Salvia miltiorrhiza, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 28/January/2018, 10.51 pm https://genomediscovery.org/wp-content/uploads/2018/01/Tanshinone-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Tanshinone-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5-HTR1A.B-HTR2A-levels-and-attenuates-anxiety-and-depression.jpg January 28, 2018 January 28, 2018

January 27, 2018

Molecular therapy for anxiety and depression: Butyl benzyl pthalate (BBP) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 27/January/2018, 11.12 pm

Molecular therapy for anxiety and depression: Butyl benzyl pthalate (BBP) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 27/January/2018, 11.12 pm https://genomediscovery.org/wp-content/uploads/2018/01/BUTYLB1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/BUTYLB1.jpg January 27, 2018 January 27, 2018

Molecular therapy for anxiety and depression: Butyl benzyl pthalate (BBP) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 27/January/2018, 11.12 pm

Popular Post